Cargando…
Translating atherosclerosis research from bench to bedside: navigating the barriers for effective preclinical drug discovery
Cardiovascular disease (CVD) remains the leading cause of death worldwide. An ongoing challenge remains the development of novel pharmacotherapies to treat CVD, particularly atherosclerosis. Effective mechanism-informed development and translation of new drugs requires a deep understanding of the kn...
Autores principales: | May, Lauren T., Bartolo, Belinda A., Harrison, David G., Guzik, Tomasz, Drummond, Grant R., Figtree, Gemma A., Ritchie, Rebecca H., Rye, Kerry-Anne, de Haan, Judy B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727216/ https://www.ncbi.nlm.nih.gov/pubmed/36459456 http://dx.doi.org/10.1042/CS20210862 |
Ejemplares similares
-
Extracellular RNA in kidney disease: moving slowly but surely from bench to bedside
por: Hunter, Robert W., et al.
Publicado: (2020) -
Microvesicles in Atherosclerosis and Angiogenesis: From Bench to Bedside and Reverse
por: Badimon, Lina, et al.
Publicado: (2017) -
The Role of Colchicine in Atherosclerosis: From Bench to Bedside
por: González, Leticia, et al.
Publicado: (2022) -
Coronary atherosclerosis and chemotherapy: From bench to bedside
por: Zhou, Fanghui, et al.
Publicado: (2023) -
Decoding microRNA drivers in atherosclerosis
por: Vartak, Tanwi, et al.
Publicado: (2022)